Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 108 entries
Sorted by: Best Match Show Resources per page
Acousto-optic pulse picking scheme with carrier-frequency-to-pulse-repetition-rate synchronization.

Optics express

de Vries O, Saule T, Plötner M, Lücking F, Eidam T, Hoffmann A, Klenke A, Hädrich S, Limpert J, Holzberger S, Schreiber T, Eberhardt R, Pupeza I, Tünnermann A.
PMID: 26367616
Opt Express. 2015 Jul 27;23(15):19586-95. doi: 10.1364/OE.23.019586.

We introduce and experimentally validate a pulse picking technique based on a travelling-wave-type acousto-optic modulator (AOM) having the AOM carrier frequency synchronized to the repetition rate of the original pulse train. As a consequence, the phase noise characteristic of...

Cite
de Vries O, Saule T, Plötner M, et al. Acousto-optic pulse picking scheme with carrier-frequency-to-pulse-repetition-rate synchronization. Opt Express. 2015;23(15):19586-95doi: 10.1364/OE.23.019586.
de Vries, O., Saule, T., Plötner, M., Lücking, F., Eidam, T., Hoffmann, A., Klenke, A., Hädrich, S., Limpert, J., Holzberger, S., Schreiber, T., Eberhardt, R., Pupeza, I., & Tünnermann, A. (2015). Acousto-optic pulse picking scheme with carrier-frequency-to-pulse-repetition-rate synchronization. Optics express, 23(15), 19586-95. https://doi.org/10.1364/OE.23.019586
de Vries, Oliver, et al. "Acousto-optic pulse picking scheme with carrier-frequency-to-pulse-repetition-rate synchronization." Optics express vol. 23,15 (2015): 19586-95. doi: https://doi.org/10.1364/OE.23.019586
de Vries O, Saule T, Plötner M, Lücking F, Eidam T, Hoffmann A, Klenke A, Hädrich S, Limpert J, Holzberger S, Schreiber T, Eberhardt R, Pupeza I, Tünnermann A. Acousto-optic pulse picking scheme with carrier-frequency-to-pulse-repetition-rate synchronization. Opt Express. 2015 Jul 27;23(15):19586-95. doi: 10.1364/OE.23.019586. PMID: 26367616.
Copy Download .nbib Format: NLM
Femtosecond Enhancement Cavities in the Nonlinear Regime.

Physical review letters

Holzberger S, Lilienfein N, Carstens H, Saule T, Högner M, Lücking F, Trubetskov M, Pervak V, Eidam T, Limpert J, Tünnermann A, Fill E, Krausz F, Pupeza I.
PMID: 26207470
Phys Rev Lett. 2015 Jul 10;115(2):023902. doi: 10.1103/PhysRevLett.115.023902. Epub 2015 Jul 08.

We combine high-finesse optical resonators and spatial-spectral interferometry to a highly phase-sensitive investigation technique for nonlinear light-matter interactions. We experimentally validate an ab initio model for the nonlinear response of a resonator housing a gas target, permitting the global...

Cite
Holzberger S, Lilienfein N, Carstens H, et al. Femtosecond Enhancement Cavities in the Nonlinear Regime. Phys Rev Lett. 2015;115(2):023902doi: 10.1103/PhysRevLett.115.023902.
Holzberger, S., Lilienfein, N., Carstens, H., Saule, T., Högner, M., Lücking, F., Trubetskov, M., Pervak, V., Eidam, T., Limpert, J., Tünnermann, A., Fill, E., Krausz, F., & Pupeza, I. (2015). Femtosecond Enhancement Cavities in the Nonlinear Regime. Physical review letters, 115(2), 023902. https://doi.org/10.1103/PhysRevLett.115.023902
Holzberger, S, et al. "Femtosecond Enhancement Cavities in the Nonlinear Regime." Physical review letters vol. 115,2 (2015): 023902. doi: https://doi.org/10.1103/PhysRevLett.115.023902
Holzberger S, Lilienfein N, Carstens H, Saule T, Högner M, Lücking F, Trubetskov M, Pervak V, Eidam T, Limpert J, Tünnermann A, Fill E, Krausz F, Pupeza I. Femtosecond Enhancement Cavities in the Nonlinear Regime. Phys Rev Lett. 2015 Jul 10;115(2):023902. doi: 10.1103/PhysRevLett.115.023902. Epub 2015 Jul 08. PMID: 26207470.
Copy Download .nbib Format: NLM
Electrophoretic properties of BSA-coated quantum dots.

Analytical and bioanalytical chemistry

Bücking W, Massadeh S, Merkulov A, Xu S, Nann T.
PMID: 19756532
Anal Bioanal Chem. 2010 Feb;396(3):1087-94. doi: 10.1007/s00216-009-3107-z. Epub 2009 Sep 13.

Low toxic InP/ZnS quantum dots (QDs), ZnS:Mn(2+)/ZnS nanocrystals and CdSe/ZnS nanoparticles were rendered water-dispersible by different ligand-exchange methods. Eventually, they were coated with bovine serum albumin (BSA) as a model protein. All particles were characterised by isotachophoresis (ITP), laser...

Cite
Bücking W, Massadeh S, Merkulov A, et al. Electrophoretic properties of BSA-coated quantum dots. Anal Bioanal Chem. 2009;396(3):1087-94doi: 10.1007/s00216-009-3107-z.
Bücking, W., Massadeh, S., Merkulov, A., Xu, S., & Nann, T. (2010). Electrophoretic properties of BSA-coated quantum dots. Analytical and bioanalytical chemistry, 396(3), 1087-94. https://doi.org/10.1007/s00216-009-3107-z
Bücking, Wendelin, et al. "Electrophoretic properties of BSA-coated quantum dots." Analytical and bioanalytical chemistry vol. 396,3 (2010): 1087-94. doi: https://doi.org/10.1007/s00216-009-3107-z
Bücking W, Massadeh S, Merkulov A, Xu S, Nann T. Electrophoretic properties of BSA-coated quantum dots. Anal Bioanal Chem. 2010 Feb;396(3):1087-94. doi: 10.1007/s00216-009-3107-z. Epub 2009 Sep 13. PMID: 19756532.
Copy Download .nbib Format: NLM
Long-term carrier-envelope-phase-stable few-cycle pulses by use of the feed-forward method.

Optics letters

Lücking F, Assion A, Apolonski A, Krausz F, Steinmeyer G.
PMID: 22660126
Opt Lett. 2012 Jun 01;37(11):2076-8. doi: 10.1364/OL.37.002076.

The feed-forward technique has recently revolutionized carrier-envelope phase (CEP) stabilization, enabling unprecedented values of residual phase jitter. Nevertheless, its demonstrations have hitherto remained in a proof-of-principle state. Here we show that pulse quality and power issues can be solved,...

Cite
Lücking F, Assion A, Apolonski A, et al. Long-term carrier-envelope-phase-stable few-cycle pulses by use of the feed-forward method. Opt Lett. 2012;37(11):2076-8doi: 10.1364/OL.37.002076.
Lücking, F., Assion, A., Apolonski, A., Krausz, F., & Steinmeyer, G. (2012). Long-term carrier-envelope-phase-stable few-cycle pulses by use of the feed-forward method. Optics letters, 37(11), 2076-8. https://doi.org/10.1364/OL.37.002076
Lücking, Fabian, et al. "Long-term carrier-envelope-phase-stable few-cycle pulses by use of the feed-forward method." Optics letters vol. 37,11 (2012): 2076-8. doi: https://doi.org/10.1364/OL.37.002076
Lücking F, Assion A, Apolonski A, Krausz F, Steinmeyer G. Long-term carrier-envelope-phase-stable few-cycle pulses by use of the feed-forward method. Opt Lett. 2012 Jun 01;37(11):2076-8. doi: 10.1364/OL.37.002076. PMID: 22660126.
Copy Download .nbib Format: NLM
A without-prejudice list of generic names of fungi for protection under the International Code of Nomenclature for algae, fungi, and plants.

IMA fungus

Kirk PM, Stalpers JA, Braun U, Crous PW, Hansen K, Hawksworth DL, Hyde KD, Lücking R, Lumbsch TH, Rossman AY, Seifert KA, Stadler M.
PMID: 24563844
IMA Fungus. 2013 Dec;4(2):381-443. doi: 10.5598/imafungus.2013.04.02.17. Epub 2013 Dec 18.

As a first step towards the production of a List of Protected Generic Names for Fungi, a without-prejudice list is presented here as a basis for future discussion and the production of a List for formal adoption. We include...

Cite
Kirk PM, Stalpers JA, Braun U, et al. A without-prejudice list of generic names of fungi for protection under the International Code of Nomenclature for algae, fungi, and plants. IMA Fungus. 2013;4(2):381-443doi: 10.5598/imafungus.2013.04.02.17.
Kirk, P. M., Stalpers, J. A., Braun, U., Crous, P. W., Hansen, K., Hawksworth, D. L., Hyde, K. D., Lücking, R., Lumbsch, T. H., Rossman, A. Y., Seifert, K. A., & Stadler, M. (2013). A without-prejudice list of generic names of fungi for protection under the International Code of Nomenclature for algae, fungi, and plants. IMA fungus, 4(2), 381-443. https://doi.org/10.5598/imafungus.2013.04.02.17
Kirk, Paul M, et al. "A without-prejudice list of generic names of fungi for protection under the International Code of Nomenclature for algae, fungi, and plants." IMA fungus vol. 4,2 (2013): 381-443. doi: https://doi.org/10.5598/imafungus.2013.04.02.17
Kirk PM, Stalpers JA, Braun U, Crous PW, Hansen K, Hawksworth DL, Hyde KD, Lücking R, Lumbsch TH, Rossman AY, Seifert KA, Stadler M. A without-prejudice list of generic names of fungi for protection under the International Code of Nomenclature for algae, fungi, and plants. IMA Fungus. 2013 Dec;4(2):381-443. doi: 10.5598/imafungus.2013.04.02.17. Epub 2013 Dec 18. PMID: 24563844; PMCID: PMC3905950.
Copy Download .nbib Format: NLM
Rapid Assembly of Oligosaccharides: Total Synthesis of a Glycosylphosphatidylinositol Anchor of Trypanosoma brucei.

Angewandte Chemie (International ed. in English)

Baeschlin DK, Chaperon AR, Charbonneau V, Green LG, Ley SV, Lücking U, Walther E.
PMID: 29711276
Angew Chem Int Ed Engl. 1998 Dec 31;37(24):3423-3428. doi: 10.1002/(SICI)1521-3773(19981231)37:24<3423::AID-ANIE3423>3.0.CO;2-I.

Six building blocks, six reaction steps: The recently developed innovative methodology facilitated the convergent synthesis of the complex oligosaccharide core 1 (shown here with protecting groups) for the total synthesis of a glycosylphosphatidylinositol (GPI) anchor. The key factors are...

Cite
Baeschlin DK, Chaperon AR, Charbonneau V, et al. Rapid Assembly of Oligosaccharides: Total Synthesis of a Glycosylphosphatidylinositol Anchor of Trypanosoma brucei. Angew Chem Int Ed Engl. 1998;37(24):3423-3428doi: 10.1002/(SICI)1521-3773(19981231)37:24<3423::AID-ANIE3423>3.0.CO;2-I.
Baeschlin, D. K., Chaperon, A. R., Charbonneau, V., Green, L. G., Ley, S. V., Lücking, U., & Walther, E. (1998). Rapid Assembly of Oligosaccharides: Total Synthesis of a Glycosylphosphatidylinositol Anchor of Trypanosoma brucei. Angewandte Chemie (International ed. in English), 37(24), 3423-3428. https://doi.org/10.1002/(SICI)1521-3773(19981231)37:24<3423::AID-ANIE3423>3.0.CO;2-I
Baeschlin, Daniel K, et al. "Rapid Assembly of Oligosaccharides: Total Synthesis of a Glycosylphosphatidylinositol Anchor of Trypanosoma brucei." Angewandte Chemie (International ed. in English) vol. 37,24 (1998): 3423-3428. doi: https://doi.org/10.1002/(SICI)1521-3773(19981231)37:24<3423::AID-ANIE3423>3.0.CO;2-I
Baeschlin DK, Chaperon AR, Charbonneau V, Green LG, Ley SV, Lücking U, Walther E. Rapid Assembly of Oligosaccharides: Total Synthesis of a Glycosylphosphatidylinositol Anchor of Trypanosoma brucei. Angew Chem Int Ed Engl. 1998 Dec 31;37(24):3423-3428. doi: 10.1002/(SICI)1521-3773(19981231)37:24<3423::AID-ANIE3423>3.0.CO;2-I. PMID: 29711276.
Copy Download .nbib Format: NLM
Draft Genome Sequence of .

Microbiology resource announcements

Raths R, Peta V, Bücking H.
PMID: 31395629
Microbiol Resour Announc. 2019 Aug 08;8(32). doi: 10.1128/MRA.00410-19.

From farmed corn soil in California, we isolated and sequenced a new member of the genus

Cite
Raths R, Peta V, Bücking H. Draft Genome Sequence of . Microbiol Resour Announc. 2019;8(32)doi: 10.1128/MRA.00410-19.
Raths, R., Peta, V., & Bücking, H. (2019). Draft Genome Sequence of . Microbiology resource announcements, 8(32), . https://doi.org/10.1128/MRA.00410-19
Raths, Rachel, et al. "Draft Genome Sequence of ." Microbiology resource announcements vol. 8,32 (2019). doi: https://doi.org/10.1128/MRA.00410-19
Raths R, Peta V, Bücking H. Draft Genome Sequence of . Microbiol Resour Announc. 2019 Aug 08;8(32). doi: 10.1128/MRA.00410-19. PMID: 31395629; PMCID: PMC6687916.
Copy Download .nbib Format: NLM
BAY-8400: A Novel Potent and Selective DNA-PK Inhibitor which Shows Synergistic Efficacy in Combination with Targeted Alpha Therapies.

Journal of medicinal chemistry

Berger M, Wortmann L, Buchgraber P, Lücking U, Zitzmann-Kolbe S, Wengner AM, Bader B, Bömer U, Briem H, Eis K, Rehwinkel H, Bartels F, Moosmayer D, Eberspächer U, Lienau P, Hammer S, Schatz CA, Wang Q, Wang Q, Mumberg D, Nising CF, Siemeister G.
PMID: 34428039
J Med Chem. 2021 Sep 09;64(17):12723-12737. doi: 10.1021/acs.jmedchem.1c00762. Epub 2021 Aug 24.

Eukaryotes have evolved two major pathways to repair potentially lethal DNA double-strand breaks. Homologous recombination represents a precise, DNA-template-based mechanism available during the S and G2 cell cycle phase, whereas non-homologous end joining, which requires DNA-dependent protein kinase (DNA-PK),...

Cite
Berger M, Wortmann L, Buchgraber P, et al. BAY-8400: A Novel Potent and Selective DNA-PK Inhibitor which Shows Synergistic Efficacy in Combination with Targeted Alpha Therapies. J Med Chem. 2021;64(17):12723-12737doi: 10.1021/acs.jmedchem.1c00762.
Berger, M., Wortmann, L., Buchgraber, P., Lücking, U., Zitzmann-Kolbe, S., Wengner, A. M., Bader, B., Bömer, U., Briem, H., Eis, K., Rehwinkel, H., Bartels, F., Moosmayer, D., Eberspächer, U., Lienau, P., Hammer, S., Schatz, C. A., Wang, Q., Wang, Q., Mumberg, D., Nising, C. F., & Siemeister, G. (2021). BAY-8400: A Novel Potent and Selective DNA-PK Inhibitor which Shows Synergistic Efficacy in Combination with Targeted Alpha Therapies. Journal of medicinal chemistry, 64(17), 12723-12737. https://doi.org/10.1021/acs.jmedchem.1c00762
Berger, Markus, et al. "BAY-8400: A Novel Potent and Selective DNA-PK Inhibitor which Shows Synergistic Efficacy in Combination with Targeted Alpha Therapies." Journal of medicinal chemistry vol. 64,17 (2021): 12723-12737. doi: https://doi.org/10.1021/acs.jmedchem.1c00762
Berger M, Wortmann L, Buchgraber P, Lücking U, Zitzmann-Kolbe S, Wengner AM, Bader B, Bömer U, Briem H, Eis K, Rehwinkel H, Bartels F, Moosmayer D, Eberspächer U, Lienau P, Hammer S, Schatz CA, Wang Q, Wang Q, Mumberg D, Nising CF, Siemeister G. BAY-8400: A Novel Potent and Selective DNA-PK Inhibitor which Shows Synergistic Efficacy in Combination with Targeted Alpha Therapies. J Med Chem. 2021 Sep 09;64(17):12723-12737. doi: 10.1021/acs.jmedchem.1c00762. Epub 2021 Aug 24. PMID: 34428039.
Copy Download .nbib Format: NLM
Increased Geriatric Treatment Frequency Improves Mobility and Secondary Fracture Prevention in Older Adult Hip Fracture Patients-An Observational Cohort Study of 23,828 Patients from the Registry for Geriatric Trauma (ATR-DGU).

Journal of clinical medicine

Gleich J, Fleischhacker E, Rascher K, Friess T, Kammerlander C, Böcker W, Bücking B, Liener U, Drey M, Höfer C, Neuerburg C.
PMID: 34884190
J Clin Med. 2021 Nov 23;10(23). doi: 10.3390/jcm10235489.

Interdisciplinary orthogeriatric care of older adult hip fracture patients is of growing importance due to an ageing population, yet there is ongoing disagreement about the most effective model of care. This study aimed to compare different forms of orthogeriatric...

Cite
Gleich J, Fleischhacker E, Rascher K, et al. Increased Geriatric Treatment Frequency Improves Mobility and Secondary Fracture Prevention in Older Adult Hip Fracture Patients-An Observational Cohort Study of 23,828 Patients from the Registry for Geriatric Trauma (ATR-DGU). J Clin Med. 2021;10(23)doi: 10.3390/jcm10235489.
Gleich, J., Fleischhacker, E., Rascher, K., Friess, T., Kammerlander, C., Böcker, W., Bücking, B., Liener, U., Drey, M., Höfer, C., & Neuerburg, C. (2021). Increased Geriatric Treatment Frequency Improves Mobility and Secondary Fracture Prevention in Older Adult Hip Fracture Patients-An Observational Cohort Study of 23,828 Patients from the Registry for Geriatric Trauma (ATR-DGU). Journal of clinical medicine, 10(23), . https://doi.org/10.3390/jcm10235489
Gleich, Johannes, et al. "Increased Geriatric Treatment Frequency Improves Mobility and Secondary Fracture Prevention in Older Adult Hip Fracture Patients-An Observational Cohort Study of 23,828 Patients from the Registry for Geriatric Trauma (ATR-DGU)." Journal of clinical medicine vol. 10,23 (2021). doi: https://doi.org/10.3390/jcm10235489
Gleich J, Fleischhacker E, Rascher K, Friess T, Kammerlander C, Böcker W, Bücking B, Liener U, Drey M, Höfer C, Neuerburg C. Increased Geriatric Treatment Frequency Improves Mobility and Secondary Fracture Prevention in Older Adult Hip Fracture Patients-An Observational Cohort Study of 23,828 Patients from the Registry for Geriatric Trauma (ATR-DGU). J Clin Med. 2021 Nov 23;10(23). doi: 10.3390/jcm10235489. PMID: 34884190.
Copy Download .nbib Format: NLM
Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee.

Neurology

Pringsheim T, Day GS, Smith DB, Rae-Grant A, Licking N, Armstrong MJ, de Bie RMA, Roze E, Miyasaki JM, Hauser RA, Espay AJ, Martello JP, Gurwell JA, Billinghurst L, Sullivan K, Fitts MS, Cothros N, Hall DA, Rafferty M, Hagerbrant L, Hastings T, O'Brien MD, Silsbee H, Gronseth G, Lang AE.
PMID: 34782410
Neurology. 2021 Nov 16;97(20):942-957. doi: 10.1212/WNL.0000000000012868.

BACKGROUND AND OBJECTIVES: To review the current evidence on the options available for initiating dopaminergic treatment of motor symptoms in early-stage Parkinson disease and provide recommendations to clinicians.METHODS: A multidisciplinary panel developed practice recommendations, integrating findings from a systematic...

Cite
Pringsheim T, Day GS, Smith DB, et al. Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee. Neurology. 2021;97(20):942-957doi: 10.1212/WNL.0000000000012868.
Pringsheim, T., Day, G. S., Smith, D. B., Rae-Grant, A., Licking, N., Armstrong, M. J., de Bie, R. M. A., Roze, E., Miyasaki, J. M., Hauser, R. A., Espay, A. J., Martello, J. P., Gurwell, J. A., Billinghurst, L., Sullivan, K., Fitts, M. S., Cothros, N., Hall, D. A., Rafferty, M., Hagerbrant, L., Hastings, T., O'Brien, M. D., Silsbee, H., Gronseth, G., Lang, A. E. (2021). Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee. Neurology, 97(20), 942-957. https://doi.org/10.1212/WNL.0000000000012868
Pringsheim, Tamara, et al. "Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee." Neurology vol. 97,20 (2021): 942-957. doi: https://doi.org/10.1212/WNL.0000000000012868
Pringsheim T, Day GS, Smith DB, Rae-Grant A, Licking N, Armstrong MJ, de Bie RMA, Roze E, Miyasaki JM, Hauser RA, Espay AJ, Martello JP, Gurwell JA, Billinghurst L, Sullivan K, Fitts MS, Cothros N, Hall DA, Rafferty M, Hagerbrant L, Hastings T, O'Brien MD, Silsbee H, Gronseth G, Lang AE. Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee. Neurology. 2021 Nov 16;97(20):942-957. doi: 10.1212/WNL.0000000000012868. PMID: 34782410.
Copy Download .nbib Format: NLM
Pressure-controlled intermittent coronary sinus occlusion improves the vasodilatory microvascular capacity and reduces myocardial injury in patients with STEMI.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Scarsini R, Terentes-Printzios D, Shanmuganathan M, Kotronias RA, Borlotti A, Marin F, Langrish J, Lucking A, Ribichini F, Kharbanda R, Ferreira VM, Channon KM, De Maria GL, Banning AP.
PMID: 34051133
Catheter Cardiovasc Interv. 2021 May 29; doi: 10.1002/ccd.29793. Epub 2021 May 29.

BACKGROUND: Preliminary data suggest that pressure-controlled intermittent coronary sinus occlusion (PICSO) might reduce the infarct size (IS) in patients with anterior ST-elevation myocardial infarction (STEMI). However, the applicability of this therapy to patients with inferior STEMI and its exact...

Cite
Scarsini R, Terentes-Printzios D, Shanmuganathan M, et al. Pressure-controlled intermittent coronary sinus occlusion improves the vasodilatory microvascular capacity and reduces myocardial injury in patients with STEMI. Catheter Cardiovasc Interv. 2021;doi: 10.1002/ccd.29793.
Scarsini, R., Terentes-Printzios, D., Shanmuganathan, M., Kotronias, R. A., Borlotti, A., Marin, F., Langrish, J., Lucking, A., Ribichini, F., Kharbanda, R., Ferreira, V. M., Channon, K. M., De Maria, G. L., & Banning, A. P. (2021). Pressure-controlled intermittent coronary sinus occlusion improves the vasodilatory microvascular capacity and reduces myocardial injury in patients with STEMI. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, . https://doi.org/10.1002/ccd.29793
Scarsini, Roberto, et al. "Pressure-controlled intermittent coronary sinus occlusion improves the vasodilatory microvascular capacity and reduces myocardial injury in patients with STEMI." Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions vol. (2021). doi: https://doi.org/10.1002/ccd.29793
Scarsini R, Terentes-Printzios D, Shanmuganathan M, Kotronias RA, Borlotti A, Marin F, Langrish J, Lucking A, Ribichini F, Kharbanda R, Ferreira VM, Channon KM, De Maria GL, Banning AP. Pressure-controlled intermittent coronary sinus occlusion improves the vasodilatory microvascular capacity and reduces myocardial injury in patients with STEMI. Catheter Cardiovasc Interv. 2021 May 29; doi: 10.1002/ccd.29793. Epub 2021 May 29. PMID: 34051133.
Copy Download .nbib Format: NLM
[Organ donation: A treatment option in end-of life intensive care?].

Deutsche medizinische Wochenschrift (1946)

Lücking KM, Söffker G.
PMID: 34416776
Dtsch Med Wochenschr. 2021 Aug;146(16):1077-1084. doi: 10.1055/a-1004-6781. Epub 2021 Aug 20.

A newly issued policy statement of the German Medical Association considers organ donation as an integral part of end-of-life intensive care in patients with devastating brain afflictions. Hence, patients' wishes towards organ donation and medical suitability should be evaluated...

Cite
Lücking KM, Söffker G. Die Organspende als Option in der intensivmedizinischen Behandlung am Lebensende. [Organ donation: A treatment option in end-of life intensive care?]. Dtsch Med Wochenschr. 2021;146(16):1077-1084doi: 10.1055/a-1004-6781.
Lücking, K. M., & Söffker, G. (2021). Die Organspende als Option in der intensivmedizinischen Behandlung am Lebensende. [Organ donation: A treatment option in end-of life intensive care?]. Deutsche medizinische Wochenschrift (1946), 146(16), 1077-1084. https://doi.org/10.1055/a-1004-6781
Lücking, Klaus Michael, and Söffker, Gerold. "Die Organspende als Option in der intensivmedizinischen Behandlung am Lebensende." [Organ donation: A treatment option in end-of life intensive care?]. Deutsche medizinische Wochenschrift (1946) vol. 146,16 (2021): 1077-1084. doi: https://doi.org/10.1055/a-1004-6781
Lücking KM, Söffker G. Die Organspende als Option in der intensivmedizinischen Behandlung am Lebensende. [Organ donation: A treatment option in end-of life intensive care?]. Dtsch Med Wochenschr. 2021 Aug;146(16):1077-1084. doi: 10.1055/a-1004-6781. Epub 2021 Aug 20. German. PMID: 34416776.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 108 entries